Loading...

Intracellular Staining Permeabilization Wash Buffer (10X) Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL SEK790
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  2. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  3. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  4. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  5. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  6. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  7. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  8. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  9. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  10. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  11. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  12. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  13. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  14. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  15. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  16. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  17. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  18. Chan L, et al. 2022. Cells. 12: . PubMed
  19. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  20. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  21. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  22. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  23. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  24. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  25. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  26. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  27. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  28. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  29. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  30. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  31. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  32. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  33. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  34. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  35. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  36. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  37. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  38. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  39. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  40. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  41. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  42. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  43. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  44. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  45. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  46. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  47. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  48. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  49. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  50. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  51. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  52. Kim S, et al. 2020. Development. 147:00:00. PubMed
  53. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  54. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  55. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  56. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  57. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  58. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  59. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  60. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  61. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  62. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  63. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  64. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  65. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  66. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  67. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  68. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  69. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  70. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  71. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  72. Poli V, et al. 2021. iScience. 24:103256. PubMed
  73. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  74. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  75. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  76. Stewart CA, et al. 2020. bioRxiv. . PubMed
  77. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  78. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  79. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  80. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  81. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  82. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  83. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  84. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  85. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  86. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  87. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  88. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  89. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  90. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  91. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  92. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  93. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  94. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  95. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  96. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  97. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  98. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  99. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  100. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  101. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  102. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  103. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  104. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  105. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  106. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  107. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  108. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  109. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  110. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  111. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  112. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  113. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  114. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  115. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  116. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  117. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  118. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  119. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  120. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  121. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  122. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  123. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  124. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  125. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  126. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  127. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  128. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  129. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  130. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  131. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  132. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  133. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  134. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  135. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  136. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  139. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  140. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  141. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  142. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  143. Kim S, et al. 2020. Development. . PubMed
  144. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  145. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  146. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  147. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  148. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  149. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  150. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  151. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  152. Ma K, et al. 2022. iScience. 25:104347. PubMed
  153. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  154. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  155. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  156. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  157. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  158. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  159. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  160. Lau H, et al. 2020. Islets. 41:12. PubMed
  161. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  162. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  163. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  164. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  165. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  166. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  167. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  168. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  169. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  170. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  171. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  172. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  173. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  174. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  175. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  176. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  177. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  178. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  179. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  180. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  181. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  182. Lee G, et al. 2021. Viruses. 13: . PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  186. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  187. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  188. Su Y, et al. 2020. Cell. 1479:183. PubMed
  189. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  190. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  191. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  192. Wang X, et al. 2022. Elife. 11:. PubMed
  193. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  194. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  195. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  196. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  197. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  205. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  206. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  207. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  208. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  209. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  210. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  211. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  212. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  213. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  214. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  215. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  216. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  217. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  218. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  219. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  220. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  221. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  222. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  223. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  224. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  225. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  226. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  227. Chan L, et al. 2022. Cells. 12: . PubMed
  228. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  229. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  230. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  231. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  232. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  233. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  234. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  235. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  236. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  237. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  238. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  239. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  240. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  241. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  242. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  243. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  244. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  245. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  246. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  247. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  248. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  249. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  250. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  251. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  252. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  253. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  254. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  255. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  256. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  257. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  258. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  259. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  260. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  261. Kim S, et al. 2020. Development. 147:00:00. PubMed
  262. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  263. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  264. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  265. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  266. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  267. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  268. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  269. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  270. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  271. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  272. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  273. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  274. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  275. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  276. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  277. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  278. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  279. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  280. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  281. Poli V, et al. 2021. iScience. 24:103256. PubMed
  282. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  283. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  284. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  285. Stewart CA, et al. 2020. bioRxiv. . PubMed
  286. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  287. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  288. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  289. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  290. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  291. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  292. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  293. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  294. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  295. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  296. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  297. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  298. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  299. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  300. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  301. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  302. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  303. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  304. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  305. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  306. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  307. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  308. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  309. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  310. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  311. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  312. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  313. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  314. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  315. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  316. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  317. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  318. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  319. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  320. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  321. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  322. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  323. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  324. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  325. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  326. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  327. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  328. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  329. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  330. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  331. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  332. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  333. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  334. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  335. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  336. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  337. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  338. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  339. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  340. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  341. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  342. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  343. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  344. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  345. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  346. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  347. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  348. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  349. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  350. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  351. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  352. Kim S, et al. 2020. Development. . PubMed
  353. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  354. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  355. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  356. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  357. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  358. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  359. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  360. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  361. Ma K, et al. 2022. iScience. 25:104347. PubMed
  362. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  363. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  364. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  365. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  366. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  367. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  368. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  369. Lau H, et al. 2020. Islets. 41:12. PubMed
  370. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  371. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  372. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  373. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  374. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  375. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  376. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  377. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  378. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  379. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  380. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  381. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  382. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  383. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  384. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  385. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  386. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  387. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  388. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  389. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  390. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  391. Lee G, et al. 2021. Viruses. 13: . PubMed
  392. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  393. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  394. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  395. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  396. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  397. Su Y, et al. 2020. Cell. 1479:183. PubMed
  398. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  399. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  400. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  401. Wang X, et al. 2022. Elife. 11:. PubMed
  402. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  403. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  404. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  405. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  406. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  407. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  408. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  414. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  415. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  416. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  417. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  418. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08-26-2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL SEK790
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  2. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  3. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  4. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  5. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  6. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  7. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  8. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  9. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  10. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  11. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  12. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  13. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  14. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  15. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  16. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  17. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  18. Chan L, et al. 2022. Cells. 12: . PubMed
  19. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  20. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  21. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  22. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  23. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  24. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  25. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  26. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  27. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  28. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  29. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  30. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  31. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  32. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  33. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  34. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  35. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  36. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  37. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  38. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  39. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  40. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  41. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  42. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  43. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  44. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  45. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  46. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  47. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  48. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  49. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  50. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  51. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  52. Kim S, et al. 2020. Development. 147:00:00. PubMed
  53. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  54. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  55. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  56. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  57. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  58. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  59. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  60. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  61. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  62. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  63. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  64. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  65. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  66. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  67. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  68. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  69. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  70. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  71. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  72. Poli V, et al. 2021. iScience. 24:103256. PubMed
  73. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  74. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  75. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  76. Stewart CA, et al. 2020. bioRxiv. . PubMed
  77. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  78. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  79. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  80. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  81. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  82. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  83. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  84. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  85. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  86. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  87. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  88. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  89. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  90. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  91. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  92. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  93. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  94. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  95. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  96. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  97. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  98. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  99. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  100. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  101. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  102. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  103. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  104. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  105. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  106. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  107. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  108. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  109. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  110. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  111. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  112. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  113. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  114. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  115. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  116. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  117. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  118. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  119. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  120. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  121. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  122. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  123. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  124. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  125. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  126. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  127. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  128. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  129. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  130. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  131. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  132. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  133. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  134. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  135. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  136. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  139. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  140. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  141. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  142. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  143. Kim S, et al. 2020. Development. . PubMed
  144. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  145. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  146. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  147. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  148. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  149. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  150. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  151. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  152. Ma K, et al. 2022. iScience. 25:104347. PubMed
  153. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  154. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  155. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  156. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  157. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  158. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  159. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  160. Lau H, et al. 2020. Islets. 41:12. PubMed
  161. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  162. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  163. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  164. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  165. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  166. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  167. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  168. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  169. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  170. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  171. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  172. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  173. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  174. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  175. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  176. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  177. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  178. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  179. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  180. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  181. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  182. Lee G, et al. 2021. Viruses. 13: . PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  186. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  187. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  188. Su Y, et al. 2020. Cell. 1479:183. PubMed
  189. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  190. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  191. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  192. Wang X, et al. 2022. Elife. 11:. PubMed
  193. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  194. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  195. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  196. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  197. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  205. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  206. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  207. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  208. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  209. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  210. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  211. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  212. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  213. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  214. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  215. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  216. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  217. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  218. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  219. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  220. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  221. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  222. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  223. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  224. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  225. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  226. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  227. Chan L, et al. 2022. Cells. 12: . PubMed
  228. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  229. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  230. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  231. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  232. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  233. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  234. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  235. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  236. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  237. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  238. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  239. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  240. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  241. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  242. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  243. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  244. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  245. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  246. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  247. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  248. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  249. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  250. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  251. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  252. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  253. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  254. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  255. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  256. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  257. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  258. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  259. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  260. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  261. Kim S, et al. 2020. Development. 147:00:00. PubMed
  262. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  263. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  264. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  265. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  266. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  267. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  268. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  269. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  270. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  271. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  272. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  273. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  274. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  275. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  276. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  277. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  278. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  279. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  280. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  281. Poli V, et al. 2021. iScience. 24:103256. PubMed
  282. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  283. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  284. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  285. Stewart CA, et al. 2020. bioRxiv. . PubMed
  286. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  287. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  288. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  289. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  290. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  291. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  292. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  293. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  294. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  295. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  296. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  297. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  298. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  299. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  300. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  301. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  302. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  303. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  304. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  305. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  306. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  307. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  308. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  309. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  310. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  311. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  312. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  313. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  314. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  315. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  316. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  317. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  318. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  319. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  320. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  321. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  322. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  323. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  324. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  325. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  326. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  327. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  328. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  329. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  330. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  331. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  332. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  333. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  334. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  335. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  336. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  337. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  338. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  339. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  340. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  341. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  342. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  343. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  344. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  345. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  346. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  347. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  348. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  349. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  350. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  351. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  352. Kim S, et al. 2020. Development. . PubMed
  353. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  354. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  355. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  356. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  357. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  358. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  359. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  360. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  361. Ma K, et al. 2022. iScience. 25:104347. PubMed
  362. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  363. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  364. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  365. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  366. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  367. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  368. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  369. Lau H, et al. 2020. Islets. 41:12. PubMed
  370. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  371. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  372. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  373. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  374. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  375. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  376. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  377. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  378. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  379. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  380. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  381. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  382. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  383. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  384. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  385. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  386. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  387. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  388. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  389. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  390. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  391. Lee G, et al. 2021. Viruses. 13: . PubMed
  392. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  393. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  394. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  395. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  396. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  397. Su Y, et al. 2020. Cell. 1479:183. PubMed
  398. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  399. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  400. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  401. Wang X, et al. 2022. Elife. 11:. PubMed
  402. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  403. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  404. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  405. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  406. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  407. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  408. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  414. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  415. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  416. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  417. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  418. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 3    Revision Date: 08-26-2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account